力達士維他命錠狀食品
力達士維他命錠狀食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| CALCIUM PHOSPHATE, DIBASIC | CALCIUM PHOSPHATE, DIBASIC | Calcium |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Potassium |
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | Magnésium |
| RETINYL ACETATE | RETINYL ACETATE | Vitamine A |
| VITAMIN A | VITAMIN A | Not identified |
| CORN STARCH | CORN STARCH | Not identified |
| ZINC SULFATE | ZINC SULFATE | Zinc |
| COPPER GLUCONATE | COPPER GLUCONATE | Cuivre |
| MANGANESE SULFATE | MANGANESE SULFATE | Manganèse |
| FERROUS FUMARATE | FERROUS FUMARATE | Fer |
| SODIUM MOLYBDATE (VI) | SODIUM MOLYBDATE (VI) | Molybdène |
| MALTODEXTRIN | MALTODEXTRIN | Maltodextrine |
| SODIUM CITRATE | SODIUM CITRATE | Not identified |
| CITRIC ACID | CITRIC ACID | Acide citrique |
| ASCORBIC ACID | ASCORBIC ACID | Vitamine C |
| BIOTIN | BIOTIN | Biotine (vitamine B8) |
| NICOTINAMIDE | NICOTINAMIDE | Nicotinamide (vitamine B3) |
| DL-ALPHA TOCOPHERYL ACETATE | DL-ALPHA TOCOPHERYL ACETATE | Vitamine E |
| CALCIUM PANTOTHENATE | CALCIUM PANTOTHENATE | Acide pantothénique (vitamine B5) |
| VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) | VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) | Vitamine B6 |
| VITAMIN B1 (THIAMINE MONONITRATE) | VITAMIN B1 (THIAMINE MONONITRATE) | Vitamine B1 (thiamine) |
| VITAMIN B2 (RIBOFLAVIN) | VITAMIN B2 (RIBOFLAVIN) | Vitamine B2 (riboflavine) |
| FOLIC ACID | FOLIC ACID | Folates (vitamine B9) |
| VITAMIN B12 (CYANOCOBALAMIN) | VITAMIN B12 (CYANOCOBALAMIN) | Vitamine B12 |
| D-MANNITOL | D-MANNITOL | Not identified |
| CYANOCOBALAMIN | CYANOCOBALAMIN | Vitamine B12 |
| CHOLECALCIFEROL | CHOLECALCIFEROL | Vitamine D |
| VITAMIN K1 (PHYLLOQUINONE) | VITAMIN K1 (PHYLLOQUINONE) | Vitamine K |
| SODIUM SELENITE | SODIUM SELENITE | Sélénium |
| CHROMIUM CHLORIDE | CHROMIUM CHLORIDE | Chrome |
| CITRUS BIOFLAVONOIDS | CITRUS BIOFLAVONOIDS | Not identified |
| CITRUS BIOFLAVONOID | CITRUS BIOFLAVONOID | Not identified |
| POTATO STARCH | POTATO STARCH | Not identified |
| SODIUM ASCORBATE | SODIUM ASCORBATE | Vitamine C |
| TOCOPHEROLS CONCENTRATE MIXED | TOCOPHEROLS CONCENTRATE MIXED | Vitamine E |
| COENZYME Q10 | COENZYME Q10 | Ubiquinone |
| HYDROXYPROPYL METHYLCELLULOSE | HYDROXYPROPYL METHYLCELLULOSE | Not identified |
| MICROCRYSTALLINE CELLULOSE | MICROCRYSTALLINE CELLULOSE | Not identified |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | Not identified |
| POLYVINYLPYRROLIDONE | POLYVINYLPYRROLIDONE | Not identified |
| D-SORBITOL | D-SORBITOL | Not identified |
| MAGNESIUM CARBONATE | MAGNESIUM CARBONATE | Magnésium |
| HYDROXYPROPYL CELLULOSE | HYDROXYPROPYL CELLULOSE | Not identified |
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | Not identified |
| IRON OXIDES (BROWN) | IRON OXIDES (BROWN) | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- 1139083401
- Chinese name
- 力達士維他命錠狀食品
- English name
- DEVITA A-Z PLUS Q10 DEPOT TABLET
- Type
- Imported tablets and capsules
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 捷地貿易興業有限公司
- Registration date
- 2024-12-05
- Published validity end
- 2029-12-05
Original register data
View published fields and their variants
- Product name
- 力達士維他命錠狀食品
- Active ingredients
- CALCIUM PHOSPHATE, DIBASIC;;POTASSIUM CHLORIDE;;MAGNESIUM OXIDE;;RETINYL ACETATE;;VITAMIN A;;CORN STARCH;;ZINC SULFATE;;COPPER GLUCONATE;;MANGANESE SULFATE;;FERROUS FUMARATE;;SODIUM MOLYBDATE (VI);;MALTODEXTRIN;;SODIUM CITRATE;;CITRIC ACID;;SODIUM MOLYBDATE (VI);;ASCORBIC ACID;;BIOTIN;;NICOTINAMIDE;;DL-ALPHA TOCOPHERYL ACETATE;;DL-ALPHA TOCOPHERYL ACETATE;;CORN STARCH;;CALCIUM PANTOTHENATE;;VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE);;VITAMIN B1 (THIAMINE MONONITRATE);;VITAMIN B2 (RIBOFLAVIN);;FOLIC ACID;;VITAMIN B12 (CYANOCOBALAMIN);;D-MANNITOL;;CYANOCOBALAMIN;;CHOLECALCIFEROL;;VITAMIN K1 (PHYLLOQUINONE);;SODIUM SELENITE;;CHROMIUM CHLORIDE;;CITRUS BIOFLAVONOIDS;;CITRUS BIOFLAVONOID;;POTATO STARCH;;SODIUM ASCORBATE;;TOCOPHEROLS CONCENTRATE MIXED;;COENZYME Q10;;COENZYME Q10;;CORN STARCH;;HYDROXYPROPYL METHYLCELLULOSE;;MICROCRYSTALLINE CELLULOSE;;MAGNESIUM STEARATE;;POLYVINYLPYRROLIDONE;;D-SORBITOL;;MAGNESIUM CARBONATE;;HYDROXYPROPYL CELLULOSE;;MEDIUM-CHAIN TRIGLYCERIDES;;IRON OXIDES (BROWN);;
- Valid until
- 1181205
- Registration number
- 1139083401
- Licence holder
- 捷地貿易興業有限公司
- Registration date
- 1131205
- Published reference
- DHC0B390834010
- Published English name
- DEVITA A-Z PLUS Q10 DEPOT TABLET
Official source
View the official register, number 1139083401
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- CHOLECALCIFEROL
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
Sources cited by Health Canada (3)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
- DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
- COENZYME Q10
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Sources cited by Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Sources cited by Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “力達士維他命錠狀食品”, https://compoatlas.com/en/supplements/taiwan/1139083401-devita-a-z-plus-q10-depot-tablet, updated 27 October 2026.